sodium salicylate has been researched along with pd 98059 in 1 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (pd 98059) | Trials (pd 98059) | Recent Studies (post-2010) (pd 98059) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 4,939 | 3 | 1,001 |
Protein | Taxonomy | sodium salicylate (IC50) | pd 98059 (IC50) |
---|---|---|---|
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 2.8 | |
Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | 6.3 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 2.8 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 2.8 | |
Dual specificity mitogen-activated protein kinase kinase 2 | Rattus norvegicus (Norway rat) | 4.2 | |
Dual specificity mitogen-activated protein kinase kinase 1 | Rattus norvegicus (Norway rat) | 4.2 | |
Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chae, HJ; Chae, SW; Kim, HR; Reed, JC | 1 |
1 other study(ies) available for sodium salicylate and pd 98059
Article | Year |
---|---|
Salicylate regulates COX-2 expression through ERK and subsequent NF-kappaB activation in osteoblasts.
Topics: Animals; Antioxidants; Blotting, Western; Cell Line; Cyclooxygenase 2; Dinoprostone; Electrophoretic Mobility Shift Assay; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation; I-kappa B Proteins; Interferon-gamma; Isoenzymes; MAP Kinase Kinase 1; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Osteoblasts; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Reactive Oxygen Species; Signal Transduction; Sodium Salicylate; Tumor Necrosis Factor-alpha | 2004 |